ADAG: adagene.com Kompaniya qiymatining sof foydaga nisbati
Adagene (ADAG) uchun ushbu kunlik narxlar grafigi -6.80 miqdoridagi P/E koeffitsientini aks ettiradi. Adagene maxsus AI algoritmlari yordamida noyob antitanalarni ishlab chiqmoqda, bu esa sektordagi raqobatchilar uchun kirishning sezilarli to'sig'ini yaratadi. Biznes qat'iy ESG tamoyillari va ekologik xavfsizlik standartlariga rioya qiladi. Brendning moliyaviy barqarorligi yetarli likvidlik rezervlari va o'z ishlanmalari uchun klinik sinovlarning muvaffaqiyatli yakunlanishi bilan ta'minlangan.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_ADAG_-_Adagene_-_PE-Multiple "ADAG: Adagene Corp Biznesning o‘zini qoplash muddati 04.07.2022 - 11.11.2026 | 👁️GURU.Markets👁️")
Adagene Inc (ADAG) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Adagene|ADAG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Adagene Corp|ADAG - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Adagene Inc.|ADAG - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Adagene|Tezkor likvidlik koeffitsiyenti adagene.com
- foyda va bozor multiplikatorlari tafsilotlari:
ADAG - Sof foyda|Sof foyda prognozi Adagene|ADAG - P/E multiplikatori|Forvard P/E multiplikatori Adagene Corp|ADAG - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati multiplikatori Adagene Inc.|ADAG - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Adagene|ADAG - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi adagene.com|ADAG - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Adagene
Kompaniyaning har tomonlama tahlili:adagene.com ADAG
Molekulalarni skrining qilishni tezlashtirish uchun robotlashtirilgan manipulatorlarning integratsiyasi Adagene (ADAG) kompaniyasining kelgusidagi daromadliligiga bevosita ta'sir ko'rsatadi, bu esa foyda ko'rsatkichi (P/E) dinamikasida aks etadi. Ushbu koeffitsient joriy bozor kapitalizatsiyasini sof foydaga bog'laydi, bu esa investorlarga aktiv uchun to'lovning haddan tashqari yuqoriligi darajasini aniqlash va davlat subsidiyalarining ehtimoliy qisqarishi yoki soliq rejimining o'zgarishi sharoitida biznesning barqarorligini baholash imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|TRML - P/E multiplikatori|PGEN: P/E multiplikatori|Narx-foyda multiplikatori PHAR|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|P/E multiplikatori Upstream Bio, Inc.|P/E multiplikatori ZBIO|Immunome Bio (IMNM) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori GOSS (Gossamer Bio, Inc.)|kalvista.com (KALV) - Kapitalizatsiyaning foydaga nisbati|SEPN - Narxning foydaga nisbati|PVLA (Pieris Pharma) - Narx-foyda multiplikatori|SVRA: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Rigel Corp (RIGL)|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|P/E multiplikatori astriatx.com|P/E multiplikatori ENGN|RAPT Therapeutics Inc. - Narx-foyda multiplikatori|P/E multiplikatori JBIO (Aerovate Therapeutics)|P/E multiplikatori Aclaris Therapeutics, Inc ACRS|Kyverna Therapeutics - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti tizianalifesciences.com (TLSA)|Cabaletta Bio (CABA) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati VTYX (Ventyx Biosciences Inc.)|THTX (Theratechnologies Inc) - P/E multiplikatori|AVTX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ELDN|P/E multiplikatori agenusbio.com (AGEN)|Narxning foydaga nisbati Climb Bio CLYM|Kompaniya qiymatining sof foydaga nisbati ZURA|ATYR - Narxning foydaga nisbati|ImageneBio Inc (IMA) - Narx-foyda koeffitsiyenti|STTK: P/E multiplikatori|Equillium (EQ) - P/E multiplikatori|Narx-foyda koeffitsiyenti CNTB|IMUX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ATRA|Biznesning o‘zini qoplash muddati inflarx.de|Narxning foydaga nisbati X4 Pharmaceuticals XFOR|ACET - Narx-foyda koeffitsiyenti|CELU - Narxning foydaga nisbati|INmune Bio Inc (INMB) - Narx-foyda koeffitsiyenti|BRNS (Barinthus Bio) - Narx-foyda koeffitsiyenti|Kezar Life Sciences Inc (KZR) - P/E multiplikatori|Narxning foydaga nisbati SAB Biotherapeutics|Narx-foyda multiplikatori AKTX (akaritx.com)|P/E multiplikatori ENLV|QTTB - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori GOVX (GeoVax Labs Inc)|P/E multiplikatori Edesa Biotech Corp EDSA|iBio, Inc. - P/E multiplikatori|CARM (Carisma Therapeutics) - Narx-foyda multiplikatori|XTLB: P/E multiplikatori|Bolt Biotherapeutics, Inc. (BOLT) - P/E multiplikatori|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|APVO - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori AIM|ADTX - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati GRI Bio GRI|XRTX: Narx-foyda multiplikatori|ReShape Lifesciences - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Revelation Biosciences Corp|INDP: P/E multiplikatori|scinai.com (SCNI) - P/E multiplikatori|CALI (CalciMedica Inc) - P/E multiplikatori|Narx-foyda multiplikatori AFMD (Affimed Therapeutics)|P/E multiplikatori ALLK|P/E multiplikatori hookipapharma.com (HOOK)|P/E multiplikatori IGMS (IGM Biosciences)|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti iteostherapeutics.com|OCEA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati TCBP|THRD: P/E multiplikatori
